文献リスト

1) Zeisberg M, Bottiglio C, Kumar N, et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol. 2003; 285: F1060-7

2) Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003; 9: 964-8

3) Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev. 2000; 14: 627-44

4) Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005; 16: 251-63

5) Hruska KA, Mathew S, Davies MR, et al. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives. Kidney Int. 2005: S142-51

6) Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res. 2005; 97: 105-14

7) Luo G, Hofmann C, Bronckers AL, et al. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 1995; 9: 2808-20

8) Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 1995; 9: 2795-807

9) Dudley AT, Robertson EJ. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn. 1997; 208: 349-62

10) Ozkaynak E, Schnegelsberg PN, Oppermann H. Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem Biophys Res Commun. 1991; 179: 116-23

11) Sampath TK, Coughlin JE, Whetstone RM, et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem. 1990; 265: 13198-205

12) Vukicevic S, Latin V, Chen P, et al. Localization of osteogenic protein-1(bone morphogenetic protein-7)during human embryonic development: high affinity binding to basement membranes. Biochem Biophys Res Commun. 1994; 198: 693-700

13) Tanaka M, Endo S, Okuda T, et al. Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury. Kidney Int. 2008; 73: 181-91

14) Bosukonda D, Shih MS, Sampath KT, et al. Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys. Kidney Int. 2000; 58: 1902-11

15) Kazama I, Mahoney Z, Miner JH, et al. Podocyte-derived BMP7 is critical for nephron development. J Am Soc Nephrol. 2008; 19: 2181-91

16) Dunn NR, Winnier GE, Hargett LK, et al. Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev Biol. 1997; 188: 235-47

17) Miyazaki Y, Ichikawa I. Ontogeny of congenital anomalies of the kidney and urinary tract, CAKUT. Pediatr Int. 2003; 45: 598- 604

18) Miyazaki Y, Oshima K, Fogo A, et al. Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development. Kidney Int. 2003; 63: 835-44

19) Kuwayama F, Miyazaki Y, Ichikawa I. Embryogenesis of the congenital anomalies of the kidney and the urinary tract. Nephrol Dial Transplant. 2002; 17(Suppl 9): 45-7

20) Miyazaki Y, Oshima K, Fogo A, et al. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest. 2000; 105: 863-73

21) Weber S, Taylor JC, Winyard P, et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J Am Soc Nephrol. 2008; 19: 891-903

22) Brenner-Anantharam A, Cebrian C, Guillaume R, et al. Tailbud-derived mesenchyme promotes urinary tract segmentation via BMP4 signaling. Development (Cambridge, England). 2007; 134: 1967-75

23) Wang GJ, Brenner-Anantharam A, Vaughan ED, et al. Antagonism of BMP4 signaling disrupts smooth muscle investment of the ureter and ureteropelvic junction. J Urol. 2009; 181: 401-7

24) Ueda H, Miyazaki Y, Matsusaka T, et al. Bmp in podocytes is essential for normal glomerular capillary formation. J Am Soc Nephrol. 2008; 19: 685-94

25) Oxburgh L, Dudley AT, Godin RE, et al. BMP4 substitutes for loss of BMP7 during kidney development. Dev Biol. 2005; 286: 637-46

26) Vukicevic S, Basic V, Rogic D, et al. Osteogenic protein-1(bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest. 1998; 102: 202-14

27) Morrissey J, Hruska K, Guo G, et al. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol. 2002; 13(Suppl 1): S14-21

28) Mitu GM, Wang S, Hirschberg R. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol. 2007; 293: F1641-8

29) Hruska KA. Treatment of chronic tubulointerstitial disease: a new concept. Kidney Int. 2002; 61: 1911-22

30) Hruska KA, Guo G, Wozniak M, et al. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol. 2000; 279: F130-43

31) Zeisberg M, Muller GA, Kalluri R. Are there endogenous molecules that protect kidneys from injury？ The case for bone morphogenic protein- 7(BMP-7). Nephrol Dial Transplant. 2004; 19: 759-61

32) Gould SE, Day M, Jones SS, et al. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 2002; 61: 51-60

33) Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem. 2005; 280: 8094-100

34) Dudas PL, Argentieri RL, Farrell FX. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant. 2009; 24: 1406-16

35) De Petris L, Hruska KA, Chiechio S, et al. Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant. 2007; 22: 3442-50

36) Chan WL, Leung JC, Chan LY, et al. BMP-7 protects mesangial cells from injury by polymeric IgA. Kidney Int. 2008; 74: 1026-39

37) Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol. 2002; 250: 231-50

38) Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev. 2003; 24: 218-35

39) Yanagita M. BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev. 2005; 16: 309-17

40) Yanagita M, Oka M, Watabe T, et al. USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochem Biophys Res Commun. 2004; 316: 490-500

41) Yanagita M. Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int. 2006; 70: 989-93

42) Yanagita M, Okuda T, Endo S, et al. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest. 2006; 116: 70-9

43) Murashima-Suginami A, Takahashi K, Kawabata T, et al. Rudiment incisors survive and erupt as supernumerary teeth as a result of USAG-1 abrogation. Biochem Biophys Res Commun. 2007; 359: 549-55

44) Murashima-Suginami A, Takahashi K, Sakata T, et al. Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. Biochem Biophys Res Commun. 2008; 369: 1012-6

45) Itasaki N, Jones CM, Mercurio S, et al. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development. 2003; 130: 4295-305

46) Lintern KB, Guidato S, Rowe A, et al. Characterization of wise protein and its molecular mechanism to interact with both WNT and BMP signals. J Biol Chem. 2009; 284: 23159-68

47) Kobayashi T, Tanaka H, Kuwana H, et al. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun. 2005; 336: 585-95

48) Terada Y, Tanaka H, Okado T, et al. Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol. 2003; 14: 1223-33

49) Nakayama N, Han CE, Scully S, et al. A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev Biol. 2001; 232: 372-87

50) Larman BW, Karolak MJ, Adams DC, et al. Chordin-like 1 and twisted gastrulation 1 regulate BMP signaling following kidney injury. J Am Soc Nephrol. 2009; 20: 1020-31

51) Chen XM, Qi W, Pollock CA. CTGF and chronic kidney fibrosis. Frontiers in Bioscience (scholar edition). 2009; 1: 132-41

52) Qi W, Chen X, Poronnik P, et al. Transforming growth factor-beta/connective tissue growth factor axis in the kidney. Int J Biochem Cell Biol. 2008; 40: 9-13

53) Qi W, Chen X, Twigg S, et al. Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney Int. 2006; 69: 989-95

54) Lin J, Patel SR, Cheng X, et al. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med. 2005; 11: 387-93

55) Lin J, Patel SR, Wang M, et al. The cysteine-rich domain protein KCP is a suppressor of transforming growth factor beta/activin signaling in renal epithelia. Mol Cell Biol. 2006; 26: 4577-85

56) Ikeya M, Kawada M, Kiyonari H, et al. Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis. Development (Cambridge, England). 2006; 133: 4463-73

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp